Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,546 | 5,180 | 11,961 | 9,060 | 11,440 |
| Marketable Securities | N/A | 5,000 | N/A | 3,000 | 3,000 |
| TOTAL | $8,988 | $10,690 | $12,328 | $12,286 | $14,743 |
| Non-Current Assets | |||||
| PPE Net | 183 | 193 | 204 | 155 | 177 |
| Other Non-Current Assets | 18 | 18 | 18 | 18 | 18 |
| TOTAL | $201 | $211 | $222 | $173 | $195 |
| Total Assets | $9,189 | $10,901 | $12,550 | $12,459 | $14,938 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 285 | 137 | 293 | 277 | 163 |
| Accrued Expenses | 1,002 | 958 | 682 | 1,024 | 1,795 |
| TOTAL | $1,334 | $1,156 | $1,053 | $1,390 | $2,076 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 47 | 61 | 78 | 89 | 118 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,334 | $1,156 | $1,053 | $1,390 | $2,076 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,222 | 21,132 | 16,103 | 14,027 | 13,373 |
| Common Shares | 2 | 2 | 1 | 1 | 1 |
| Retained earnings | -46,882 | -44,578 | -42,372 | -40,366 | -38,082 |
| Other shareholders' equity | 6,688 | 6,869 | 9,282 | 9,470 | 9,974 |
| TOTAL | $7,855 | $9,745 | $11,497 | $11,069 | $12,862 |
| Total Liabilities And Equity | $9,189 | $10,901 | $12,550 | $12,459 | $14,938 |